Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Disorders of the Nervous System

Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex

Esther Castillo-Gómez, Marta Pérez-Rando, María Bellés, Javier Gilabert-Juan, José Vicente Llorens, Héctor Carceller, Clara Bueno-Fernández, Clara García-Mompó, Beatriz Ripoll-Martínez, Yasmina Curto, Noelia Sebastiá-Ortega, María Dolores Moltó, Julio Sanjuan and Juan Nacher
eNeuro 21 April 2017, 4 (2) ENEURO.0034-17.2017; DOI: https://doi.org/10.1523/ENEURO.0034-17.2017
Esther Castillo-Gómez
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Esther Castillo-Gómez
Marta Pérez-Rando
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marta Pérez-Rando
María Bellés
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Gilabert-Juan
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
2Department of Genetics, Universitat De València, Burjassot 46100, Spain
3 CIBERSAM: Spanish National Network for Research in Mental Health, 28029 Madrid
4Fundación Investigación Hospital Clínico De Valencia, INCLIVA, Valencia 46010, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Vicente Llorens
2Department of Genetics, Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Héctor Carceller
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Héctor Carceller
Clara Bueno-Fernández
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clara García-Mompó
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clara García-Mompó
Beatriz Ripoll-Martínez
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasmina Curto
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noelia Sebastiá-Ortega
2Department of Genetics, Universitat De València, Burjassot 46100, Spain
3 CIBERSAM: Spanish National Network for Research in Mental Health, 28029 Madrid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Dolores Moltó
2Department of Genetics, Universitat De València, Burjassot 46100, Spain
3 CIBERSAM: Spanish National Network for Research in Mental Health, 28029 Madrid
4Fundación Investigación Hospital Clínico De Valencia, INCLIVA, Valencia 46010, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María Dolores Moltó
Julio Sanjuan
3 CIBERSAM: Spanish National Network for Research in Mental Health, 28029 Madrid
4Fundación Investigación Hospital Clínico De Valencia, INCLIVA, Valencia 46010, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Nacher
1Neurobiology Unit, Cell Biology Department, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat De València, Burjassot 46100, Spain
3 CIBERSAM: Spanish National Network for Research in Mental Health, 28029 Madrid
4Fundación Investigación Hospital Clínico De Valencia, INCLIVA, Valencia 46010, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan Nacher
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Experimental procedure. Seven days after birth (P7), male pups from two different transgenic strains: the GIN mice (Oliva et al. 2000), which express EGFP in interneurons, and the THY1 mice (Feng et al. 2000), which express the YFP in pyramidal neurons) were intraperitoneally injected with MK801 or NaCl (vehicle solution). After weaning (P21), mice were randomly selected and housed alone (isolation) or in groups of four mice (social rearing) for 10 weeks. At P90, all mice were tested in the hole-board apparatus. Brains from GIN molecular mice were destined to protein and gene expression studies, whereas brains from GIN structure mice were used for the structural and neurochemical analysis of interneurons. The THY structure set of mice was used to study structural alterations of pyramidal neurons. For further details, see Material and Methods.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Behavioral analysis of GAD-EGFP expressing mice. A, Representative track-plot reports recorded during the hole-board test session (ANY-maze). Observe the increased distance traveled (purple line) in the two groups subjected to post-weaning isolation, especially in the border of the apparatus. Social isolation rearing increased locomotor activity (B) and anxiety-related behavior (D) but did not change exploratory behavior (number of head dips into novel holes/total number of head dips; C). Gray lines in graphs (B–D) represent statistically significant effects of rearing in a two-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Behavioral analysis of Thy1-YFP expressing mice. A, Representative track-plot reports showing the increased distance traveled (purple line) of double-hit mice (MK801-Isolation group) in the hole-board test compared with the other groups. Double-hit mice showed increased locomotor activity (B) and anxiety-related behavior (D) but no changes in exploratory behavior (number of head dips into novel holes/total number of head dips; C). B–D, Horizontal lines in graphs represent statistically significant effects of MK801 treatment (black), rearing (gray), or interaction (gray, dashed) in a two-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. Colored symbols in bars represent trends and statistically significant differences among groups after post hoc analysis: # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Volumetric analysis. Treatment, rearing, and the interaction of both treatments influenced the volume of the amygdala and the PFC. Although the total volume of both regions was not significantly affected (A), the volume of some nuclei of the amygdala (B, C) and some regions of the PFC (D, E) was affected by treatment (BMA, Cg1), rearing (BLA, IL), or their interaction (Ce, Cg1). Horizontal lines in graphs represent trends and statistically significant effects of MK801 treatment (black), rearing (gray), or interaction (gray, dashed) in a two-way ANOVA. # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. Colored symbols in bars represent trends and statistically significant differences among groups after post hoc analysis: # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. B, D, Schematic representations of the regions that were measured in our volumetric study (amygdala: all brain slices from bregma −0.58 to −2.30 mm; PFC: all brain slices from bregma +2.96 to −0.22 mm).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Structural analysis of pyramidal neurons. A, Panoramic view of the PFC of THY1-YFP expressing mice. Arrowheads point to fluorescent pyramidal neurons. B, Representative confocal image of a pyramidal neuron from these animals. C1 (NaCl-Group) and C2 (MK801-Isolation) represent sections of the spiny apical dendrites of these pyramidal neurons. D, E, Graphs showing the results of the analysis of dendritic spine density. D, The segmented analysis of the spine densities only showed a significant interaction effect in the first segment (0–50 µm of distance from the soma; Table 3) but no statistically significant differences among groups where observed after post hoc comparison. Despite the significant effects of treatment or rearing in some of the other segments (Table 3), the interaction (two-way ANOVA) was not significant in any of them and, therefore, post hoc comparisons were not applicable (n/a). E, No statistical significant effects of treatment, rearing, or their interaction (two-way ANOVA) were observed when analyzing the spines density of the total length of the dendrite (200 µm). Scale bars: A, 100 µm; B, 20 µm; C1, C2, 2.5 µm.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Structural analysis of interneurons. Panoramic view of the amygdala (A) and PFC (H) of GIN mice. B1, B2, I1, I2, Representative 3D reconstructions of the dendritic arbor of GAD-EGFP expressing interneurons. Double-hit mice showed increased dendritic arborization (number of intersections in the Sholl analysis) in interneurons form the amygdala (D, E) but not from the PFC (K, L). C1, C2, J1, J2, Representative images of spiny dendrites from GAD-EGFP expressing interneurons. Insets are magnified views of the squared sections of their respective images. Arrowheads point to dendritic spines. Analysis of the dendritic spines showed increased density in the PFC (M, N) but not in the amygdala (F, G) of double-hit mice. Horizontal lines in graphs (E, N) represent statistically significant effects of MK801 treatment (black), rearing (gray), or interaction (gray, dashed) in a two-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. Colored symbols (D, E, M, N) represent statistically significant differences among groups after post hoc analysis: *p < 0.05, **p < 0.01, ***p < 0.001. If the interaction (two-way ANOVA) was not significant, post hoc comparisons were not applicable (n/a). Scale bars: A, H, 800 µm; B, I, 40 µm; C, J, 14 µm; C, J (insets), 2 µm.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Excitatory and inhibitory neurotransmission. Schematic view of all the analyzed regions (A1, amygdala; B1, PFC). Right, Representative confocal images of excitatory (blue, VGLUT1) and inhibitory (red, VGAT) puncta in the neuropil of NaCl-Social and MK801-Isolated animals. Scale bars: images, 16 µm; insets, 6 µm. Significant differences in VGLUT1 puncta density (A2, B2), VGAT puncta density (A3, B3), and E/I ratio (A4, B4) among groups were observed. Horizontal lines in graphs represent trends and statistically significant effects of MK801 treatment (black), rearing (gray), or interaction (gray, dashed) in a two-way ANOVA. # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. Colored symbols in bars represent trends and statistically significant differences among groups after post hoc analysis: # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Protein and gene expression studies. Bar graphs showing the presence or lack of effect of the treatment, rearing, or their interaction in GAD67, SYN, and PSA-NCAM protein expression (A–C) and in GAD67, BDNF, ErbB4, CB1-R, ST8SiaII, and ST8SiaIV mRNA levels (D–I). Horizontal lines in graphs represent trends and statistically significant effects of MK801 treatment (black), rearing (gray) or interaction (gray, dashed) in a two-way ANOVA. # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. J & K: Representative bands from immunoblots for GAD67 (J) and SYN (K) in the amygdala and the PFC.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Expression of PNNs in PV-immunoreactive neurons. A, Representative confocal images showing the distribution of PV (red) and PNNs (blue) in the different nuclei of the amygdala (left) and regions of the PFC (right) of GIN mice (GAD-GFP, green). The squared section in the panoramic images was 2× magnified to show the different nuclei and areas that were analyzed. In a detailed view (below), two PV-immunoreactive neurons expressing PNN can be observed. GAD-GFP expressing interneurons do not express PNN. Scale bars: panoramic views, 875 µm; detailed view, 25 µm. B, C, Treatment, rearing, or their interaction affected the total number of PV neurons (B1, C1), PNNs (B2, C2), or their colocalization (B3, C3) in some nuclei of the amygdala and regions of the PFC. Horizontal lines in graphs represent trends and statistically significant effects of MK801 treatment (black), rearing (gray), or interaction (gray, dashed) in a two-way ANOVA. # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. Colored symbols in bars represent trends and statistically significant differences among groups after post hoc analysis: # 0.1 > p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001.

Tables

  • Figures
    • View popup
    Table 1.

    Sequences of gene specific primers and associated amplicon lengths for qRT-PCR

    Target genePrimersSequence (5′ → 3′)Amplicon size*
    GAD67Forward
    Reverse
    CTGGAGCTGGCTGAATACCT
    TCGGAGGCTTTGTGGTATGT
    120
    BDNFForward
    Reverse
    GGTTCGAGAGGTCTGACGAC
    CAAAGGCACTTGACTGCTGA
    159
    ErbB4Forward
    Reverse
    CAGTCGCCCAGGGTGCAACG
    GCGAACACTGTGGGGTCGGC
    133
    CB1-RForward
    Reverse
    TGTCCCTCACCCTGGGCACC
    TCCCAGGAGATCGGCCACCG
    134
    ST8SiaIIForward
    Reverse
    GGCAACTCAGGAGTCTTGCT
    GTCAGTCTTGAGGCCCACAT
    123
    ST8SiaIVForward
    Reverse
    CCTTCATGGTCAAAGGAGGA
    CCTTCATGGTCAAAGGAGGA
    125
    YwhazForward
    Reverse
    TTGAGCAGAAGACGGAAGGT
    GAAGCATTGGGGATCAAGAA
    136
    • ↵* Amplicon length in base pairs.

    • View popup
    Table 2.

    Summary of results (part I)

    ParameterMain effects (two-way ANOVA)Group differences (from NaCl-Social)
    TreatmentRearingInteractionNaCl-IsolationMK801-SocialMK801-Isolation
    Behavior (Figs. 2, 3)
        Locomotor activity
            Total distance travelled
                Gad-EGFP mice—✓(1)—n/an/an/a
                Thy1-YFP mice✓(2)✓(3)✓(4)——↑**
            Mean speed
                Gad-EGFP mice—✓(5)—n/an/an/a
                Thy1-YFP mice✓(6)✓(7)✓(8)——↑**
        Anxiety-related behavior
            Border distance
                Gad-EGFP mice—✓(9)—n/an/an/a
                Thy1-YFP mice✓(10)✓(11)—n/an/an/a
            Border entries
                Gad-EGFP mice—✓(12)—n/an/an/a
                Thy1-YFP mice✓(13)✓(14)✓(15)——↑*
            Body rotations
                Gad-EGFP mice—✓(16)—n/an/an/a
                Thy1-YFP mice✓(17)✓(18)✓(19)↑***↑*↑***
        Exploratory behavior
                Gad-EGFP mice———n/an/an/a
                Thy1-YFP mice———n/an/an/a
    Brain volume (Fig. 4)
        Amygdala
            Total volume——#(20)n/an/an/a
            Central——✓(21)↑*——
            Lateral———n/an/an/a
            Basolateral—✓(22)—n/an/an/a
            Basomedial✓(23)——n/an/an/a
            Medial———n/an/an/a
        PFC
            Total volume—#(24)—n/an/an/a
            IL—#(25)—n/an/an/a
            PrL———n/an/an/a
            Cg1✓(26)—✓(27)——↓#
            Cg2———n/an/an/a
    • ↵Symbols: (✓) statistically significant effect (two-way ANOVA); (—) no statistically significant effect (two-way ANOVA) or difference from NaCl-Social group (post hoc); (↑) increase; (n/a) not applicable; (↓) decrease; *p < 0.05; **p < 0.01; ***p < 0.001; #0.10 ≥ p ≥ 0.05.

    • F and p values: (1) F(1,58) = 31.11, p < 10−6; (2) F(1,11) = 8.05, p = 0.016; (3) F(1,11) = 9.99, p = 0.009; (4) F(1,11) = 6.74, p = 0.025; (5) F(1,59) = 19.38, p = 4.6 × 10−5; (6) F(1,11) = 7.80, p = 0.018; (7) F(1,11) = 9.90, p = 0.009; (8) F(1,11) = 6.61, p = 0.026; (9) F(1,59) = 36.48, p < 10−7; (10) F(1,11) = 8.22, p = 0.015; (11) F(1,11) = 20.68, p = 0.001; (12) F(1,60) = 6.20, p = 0.016; (13) F(1,11) = 7.48, p = 0.019; (14) F(1,11) = 6.11, p = 0.031; (15) F(1,11) = 8.27, p = 0.015; (16) F(1,60) = 5.14, p = 0.027; (17) F(1,11) = 93.50, p = 10−5; (18) F(1,11) = 119.86, p < 10 − 6; (19) F(1,11) = 42.94, p = 4.1 × 10−5; (20) F(1,20) = 3.34, p = 0.082; (21) F(1,21) = 4.73, p = 0.041; (22) F(1,21) = 9.44, p = 0.0058; (23) F(1,21) = 5.82, p = 0.025; (24) F(1,23) = 3.39, p = 0.079; (25) F(1,23) = 3.61, p = 0.07; (26) F(1,22) = 5.062, p = 0.035; (27) F(1,22) = 6.62, p = 0.017.

    • View popup
    Table 3.

    Summary of results (part II)

    ParameterMain effects (two-way ANOVA)Group differences (from NaCl-Social)
    TreatmentRearingInteractionNaCl-IsolationMK801-SocialMK801-Isolation
    Structure of pyramidal neurons (Fig. 5)
        Dendritic spines
            PFC
                50——✓(28)———
                100———n/an/an/a
                150—✓(29)—n/an/an/a
                200✓(30)——n/an/an/a
                Total———n/an/an/a
    Structure of interneurons (Fig. 6)
        Dendritic arborization
            Amygdala
                20—#(31)✓(32)———
                40—✓(33)✓(34)——↑*
                60✓(35)✓(36)✓(37)——↑***
                80✓(38)✓(39)✓(40)——↑*
                100✓(41)✓(42)#(43)n/an/an/a
                120✓(44)✓(45)✓(46)——↑*
                140#(47)——n/an/an/a
                160———n/an/an/a
                Total✓(48)✓(49)✓(50)——↑***
            PFC
                20———n/an/an/a
                40———n/an/an/a
                60———n/an/an/a
                80———n/an/an/a
                100———n/an/an/a
                120———n/an/an/a
                140———n/an/an/a
                160———n/an/an/a
                Total———n/an/an/a
        Dendritic spines
            Amygdala
                50———n/an/an/a
                100———n/an/an/a
                150—#(51)#(52)n/an/an/a
                Total———n/an/an/a
            PFC
                50#(53)✓(54)#(55)n/an/an/a
                100✓(56)✓(57)✓(58)↑*↑**↑**
                150✓(59)✓(60)—n/an/an/a
                Total✓(61)✓(62)✓(63)↑**↑***↑***
    • ↵Symbols: (✓) statistically significant effect (two-way ANOVA); (—) no statistically significant effect (two-way ANOVA) or difference from NaCl-Social group (post hoc); (↑) increase; (n/a) not applicable; (↓) decrease; *p < 0.05; **p < 0.01; ***p < 0.001; #0.10 ≥ p ≥ 0.05.

    • F and p values: (28) F(1,15) = 6.29, p = 0.024; (29) F(1,15) = 4.88, p = 0.043; (30) F(1,18) = 4.90, p = 0.043 (31) F(1,19) = 3.81, p = 0.066; (32) F(1,19) = 4.72, p = 0.043; (33) F(1,19) = 9.02, p = 0.007; (34) F(1,19) = 12.58, p = 0.002; (35) F(1,18) = 7.53, p = 0.013; (36) F(1,18) = 23.53, p = 12.8 × 10−5; (37) F(1,18) = 12.62, p = 0.002; (38) F(1,19) = 4.64, p = 0.044; (39) F(1,19) = 6.55, p = 0.019; (40) F(1,19) = 10.23, p = 0.005; (41) F(1,20) = 4.43, p = 0.048; (42) F(1,20) = 8.79, p = 0.008; (43) F(1,20) = 3.27, p = 0.086; (44) F(1,20) = 5.73, p = 0.027; (45) F(1,20) = 5.32, p = 0.032; (46) F(1,20) = 14.63, p = 0.0011; (47) F(1,20) = 4.34, p = 0.050; (48) F(1,20) = 8.31, p = 0.009; (49) F(1,20) = 14.29, p = 0.001; (50) F(1,20) = 18.23, p = 37.5 × 10−5; (51) F(1,22) = 3.79, p = 0.064; (52) F(1,22) = 3.34, p = 0.081; (53) F(1,22) = 3.74, p = 0.066; (54) F(1,22) = 4.53, p = 0.045; (55) F(1,22) = 3.31, p = 0.083; (56) F(1,22) = 11.72, p = 0.002; (57) F(1,22) = 5.50, p = 0.029; (58) F(1,22) = 5.18, p = 0.033; (59) F(1,22) = 5.50, p = 0.028; (60) F(1,22) = 7.43, p = 0.012; (61) F(1,22) = 21.08, p = 14.2 × 10−5; (62) F(1,22) = 6.27, p = 0.020; (63) F(1,22) = 10.18, p = 0.004.

    • View popup
    Table 4.

    Summary of results (part III)

    ParameterMain effects (two-way ANOVA)Group differences (from NaCl-Social)
    TreatmentRearingInteractionNaCl-IsolationMK801-SocialMK801-Isolation
    Density of neuropil puncta (Fig. 7)
        VGLUT1 (Amygdala)
            Central———n/an/an/a
            Lateral✓(64)✓(65)✓(66)——↑*
            Basolateral———n/an/an/a
            Basomedial✓(67)✓(68)#(69)n/an/an/a
            Medial#(70)✓(71)✓(72)——↑*
        VGLUT1 (PFC)
            IL+PrL———n/an/an/a
            Cg1+Cg2✓(73)✓(74)#(75)n/an/an/a
        VGAT (Amygdala)
            Central—#(76)—n/an/an/a
            Lateral—✓(77)—n/an/an/a
            Basolateral#(78)#(79)#(80)n/an/an/a
            Basomedial#(81)✓(82)—n/an/an/a
            Medial#(83)✓(84)#(85)n/an/an/a
        VGAT (PFC)
            IL+PrL#(86)#(87)✓(88)—↑*—
            Cg1+Cg2—✓(89)—n/an/an/a
    E/I Balance (Fig. 7)
        Amygdala
            Central———n/an/an/a
            Lateral#(90)✓(91)—n/an/an/a
            Basolateral—✓(92)—n/an/an/a
            Basomedial———n/an/an/a
            Medial———n/an/an/a
        PFC
            IL+PrL#(93)✓(94)✓(95)——↑*
            Cg1+Cg2✓(96)✓(97)—n/an/an/a
    • ↵Symbols: (✓) statistically significant effect (two-way ANOVA); (-) no statistically significant effect (two-way ANOVA) or difference from NaCl-Social group (post hoc); (↑) increase; (n/a) not applicable; (↓) decrease; *p < 0.05; **p < 0.01; ***p < 0.001; #0.10 ≥ p ≥ 0.05.

    • F and p values: (64) F(1,29) = 4.58, p = 0.041; (65) F(1,29) = 7.12, p = 0.012; (66) F(1,29) = 4.20, p = 0.049; (67) F(1,28) = 4.89, p = 0.036; (68) F(1,28) = 6.08, p = 0.020; (69) F(1,28) = 3.17, p = 0.086; (70) F(1,29) = 3.74, p = 0.063; (71) F(1,29) = 4.32, p = 0.047; (72) F(1,29) = 5.01, p = 0.033; (73) F(1,19) = 6.31, p = 0.021; (74) F(1,19) = 8.44, p = 0.009; (75) F(1,19) = 3.54, p = 0.075; (76) F(1,29) = 3.45, p = 0.074; (77) F(1,28) = 5.28, p = 0.029; (78) F(1,29) = 3.09, p = 0.089; (79) F(1,29) = 3.88, p = 0.058; (80) F(1,29) = 2.91, p = 0.097; (81) F(1,29) = 3.16, p = 0.086; (82) F(1,29) = 4.29, p = 0.047; (83) F(1,29) = 3.47, p = 0.073; (84) F(1,29) = 5.88, p = 0.022; (85) F(1,29) = 3.05, p = 0.091; (86) F(1,18) = 3.75, p = 0.069; (87) F(1,18) = 3.88, p = 0.065; (88) F(1,18) = 6.53, p = 0.020; (89) F(1,19) = 21.12, p = 2 × 10−4; (90) F(1,29) = 3.55, p = 0.070; (91) F(1,29) = 9.01, p = 0.005; (92) F(1,28) = 6.75, p = 0.015; (93) F(1,18) = 3.93, p = 0.063; (94) F(1,18) = 6.18, p = 0.023; (95) F(1,18) = 6.39, p = 0.021; (96) F(1,18) = 10.72, p = 0.004; (97) F(1,18) = 8.33, p = 0.0098.

    • View popup
    Table 5.

    Summary of results (part IV)

    ParameterMain effects (two-way ANOVA)Group differences (from NaCl-Social)
    TreatmentRearingInteractionNaCl-IsolationMK801-SocialMK801-Isolation
    Protein expression (Fig.7)
        GAD67
            Amygdala—✓(98)—n/an/an/a
            PFC———n/an/an/a
        SYN
            Amygdala———n/an/an/a
            PFC———n/an/an/a
        PSA-NCAM
            Amygdala✓(99)✓(100)#(101)n/an/an/a
            PFC✓(102)——n/an/an/a
    Gene expression (Fig.7)
        GAD67
            Amygdala———n/an/an/a
            PFC#(103)——n/an/an/a
        BDNF
            Amygdala———n/an/an/a
            PFC—✓(104)—n/an/an/a
        ErbB4
            Amygdala——#(105)n/an/an/a
            PFC———n/an/an/a
        CB1-R
            Amygdala—✓(106)—n/an/an/a
            PFC———n/an/an/a
        ST8SiaII
            Amygdala#(107)——n/an/an/a
            PFC———n/an/an/a
        ST8SiaIV
            Amygdala———n/an/an/a
            PFC#(108)✓(109)—n/an/an/a
    • ↵Symbols: (✓) statistically significant effect (two-way ANOVA); (—) no statistically significant effect (two-way ANOVA) or difference from NaCl-Social group (post hoc); (↑) increase; (n/a) not applicable; (↓) decrease; (*) p < 0.05; (**) p < 0.01; (***) p < 0.001; (#) 0.10 ≥ p ≥ 0.05.

    • F and p values: (98) F(1,19) = 11.74, p = 0.003; (99) F(1,25) = 11.58, p = 0.002; (100) F(1,25) = 107.23, p < 10−10; (101) F(1,25) = 4.02, p = 0.056; (102) F(1,32) = 9.863, p = 0.004; (103) F(1,25) = 3.94, p = 0.058; (104) F(1,26) = 13.51, p = 0.001; (105) F(1,25) = 4.10, p = 0.054; (106) F(1,26) = 5.52, p = 0.027; (107) F(1,20) = 3.07, p = 0.095; (108) F(1,25) = 4.12, p = 0.053; (109) F(1,25) = 5.06, p = 0.033.

    • View popup
    Table 6.

    Summary of results (part V)

    ParameterMain effects (two-way ANOVA)Group differences (from NaCl-Social)
    TreatmentRearingInteractionNaCl-IsolationMK801-SocialMK801-Isolation
    PV+ neurons (Fig. 9)
        Amygdala
            Total——#(110)n/an/an/a
            Central———n/an/an/a
            Lateral———n/an/an/a
            Basolateral——✓(111)———
            Basomedial——✓(112)——↑*
        PFC
            Total——✓(113)———
            IL—✓(114)✓(115)↑*↑**—
            PrL——✓(116)———
    PNNs (Fig. 9)
        Amygdala
            Total✓(117)—✓(118)———
            Central✓(119)——n/an/an/a
            Lateral———n/an/an/a
            Basolateral✓(120)—✓(121)———
            Basomedial#(122)✓(123)—n/an/an/a
        PFC
            Total——✓(124)—↑**—
            IL✓(125)✓(126)✓(127)↑*↑***—
            PrL———n/an/an/a
    PV-PNN colocalization (Fig. 9)
        Amygdala
            Total—✓(128)✓(129)—↑#—
            Central———n/an/an/a
            Lateral———n/an/an/a
            Basolateral——✓(130)———
            Basomedial#(131)✓(132)—n/an/an/a
        PFC
            Total—#(133)✓(134)—↑**↓#
            IL✓(135)✓(136)✓(137)—↑***—
            PrL———n/an/an/a
    • ↵Symbols: (✓) statistically significant effect (two-way ANOVA); (—) no statistically significant effect (two-way ANOVA) or difference from NaCl-Social group (post hoc); (↑) increase; (n/a) not applicable; (↓) decrease; *p < 0.05; **p < 0.01; ***p < 0.001; #0.10 ≥ p ≥ 0.05.

    • F values and p values: (110) F(1,21) = 3.99, p = 0.059; (111) F(1,18) = 7.06, p = 0.016; (112) F(1,20) = 4.80, p = 0.041; (113) F(1,14) = 12.82, p = 0.003; (114) F(1,15) = 7.22, p = 0.017; (115) F(1,15) = 52.97, p = 3 × 10−6; (116) F(1,15) = 7.03, p = 0.018; (117) F(1,20) = 5.648, p = 0.028; (118) F(1,20) = 6.70, p = 0.016; (119) F(1,18) = 10.19, p = 0.005; (120) F(1,21) = 4.91, p = 0.038; (121) F(1,21) = 12.96, p = 0.002; (122) F(1,20) = 3.39, p = 0.08; (123) F(1,20) = 6.4, p = 0.02; (124) F(1,14) = 10.55, p = 0.006; (125) F(1,15) = 12.93, p = 0.003; (126) F(1,15) = 17.92, p = 0.001; (127) F(1,15) = 88.68, p < 10 − 7; (128) F(1,19) = 10.95, p = 0.004; (129) F(1,19) = 13.36, p = 0.002; (130) F(1,19) = 6.53, p = 0.019; (131) F(1,21) = 2.99, p = 0.098; (132) F(1,21) = 4.97, p = 0.037; (133) F(1,13) = 3.61, p = 0.08; (134) F(1,13) = 15.49, p = 0.002; (135) F(1,15) = 19.87, p = 4.61 × 10−4; (136) F(1,15) = 47.52, p = 5 × 10−6; (137) F(1,15) = 87.65, p < 10−7.

Back to top

In this issue

eneuro: 4 (2)
eNeuro
Vol. 4, Issue 2
March/April 2017
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex
Esther Castillo-Gómez, Marta Pérez-Rando, María Bellés, Javier Gilabert-Juan, José Vicente Llorens, Héctor Carceller, Clara Bueno-Fernández, Clara García-Mompó, Beatriz Ripoll-Martínez, Yasmina Curto, Noelia Sebastiá-Ortega, María Dolores Moltó, Julio Sanjuan, Juan Nacher
eNeuro 21 April 2017, 4 (2) ENEURO.0034-17.2017; DOI: 10.1523/ENEURO.0034-17.2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex
Esther Castillo-Gómez, Marta Pérez-Rando, María Bellés, Javier Gilabert-Juan, José Vicente Llorens, Héctor Carceller, Clara Bueno-Fernández, Clara García-Mompó, Beatriz Ripoll-Martínez, Yasmina Curto, Noelia Sebastiá-Ortega, María Dolores Moltó, Julio Sanjuan, Juan Nacher
eNeuro 21 April 2017, 4 (2) ENEURO.0034-17.2017; DOI: 10.1523/ENEURO.0034-17.2017
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • interneuron
  • neuronal plasticity
  • PSA-NCAM
  • schizophrenia
  • social isolation
  • stress

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • Recommendations emerging from carbon emissions estimations of the Society for Neuroscience annual meeting
  • Lateralization and time-course of cortical phonological representations during syllable production
  • Protein kinase A-dependent plasticity of local inhibitory synapses from hilar somatostatin-expressing neurons
Show more New Research

Disorders of the Nervous System

  • Chemogenetic Perturbation of the Posterior But Not Anterior Cerebellum Reduces Voluntary Ethanol Consumption
  • Energy Expenditure Homeostasis Requires ErbB4, an Obesity Risk Gene, in the Paraventricular Nucleus
  • In Utero Electroporated Neurons for Medium-Throughput Screening of Compounds Regulating Neuron Morphology
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.